MEDSCI (02415) Sets 31 March 2026 Board Meeting to Approve FY 2025 Results and Dividend Proposal

Bulletin Express

Mar 19

MedSci Healthcare Holdings Limited (Stock Code: 02415) has scheduled a board meeting for 31 March 2026 in Hong Kong.

The agenda includes: 1. Reviewing and approving the audited financial results of the Group for the financial year ended 31 December 2025. 2. Considering a recommendation for a final dividend. 3. Addressing other routine corporate matters.

The meeting will be chaired by Dr. Zhang Fabao, who serves as Chairman and Executive Director. The current Board comprises four executive directors (Dr. Zhang Fabao, Dr. Li Xinmei, Mr. Wang Shuai, Mr. Cheng Liang), one non-executive director (Mr. Yan Shengfeng), and three independent non-executive directors (Ms. Liu Tao, Mr. Yu Mingyang, Mr. Lau Yiu Kwan Stanley).

The company plans to publish the audited annual results following Board approval. Any final dividend recommendation will be announced after the meeting.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1106253621"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1106253621\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1106253621?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-19 16:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1106253621","market":"us","top_or_hot":-1,"title":"MEDSCI (02415) Sets 31 March 2026 Board Meeting to Approve FY 2025 Results and Dividend Proposal","media":"Bulletin Express","content":"<p>MedSci Healthcare Holdings Limited (Stock Code: 02415) has scheduled a board meeting for 31 March 2026 in Hong Kong.</p>\n<p>The agenda includes:\n1. Reviewing and approving the audited financial results of the Group for the financial year ended 31 December 2025.\n2. Considering a recommendation for a final dividend.\n3. Addressing other routine corporate matters.</p>\n<p>The meeting will be chaired by Dr. Zhang Fabao, who serves as Chairman and Executive Director. The current Board comprises four executive directors (Dr. Zhang Fabao, Dr. Li Xinmei, Mr. Wang Shuai, Mr. Cheng Liang), one non-executive director (Mr. Yan Shengfeng), and three independent non-executive directors (Ms. Liu Tao, Mr. Yu Mingyang, Mr. Lau Yiu Kwan Stanley).</p>\n<p>The company plans to publish the audited annual results following Board approval. Any final dividend recommendation will be announced after the meeting.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MEDSCI (02415) Sets 31 March 2026 Board Meeting to Approve FY 2025 Results and Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMEDSCI (02415) Sets 31 March 2026 Board Meeting to Approve FY 2025 Results and Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-19 16:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>MedSci Healthcare Holdings Limited (Stock Code: 02415) has scheduled a board meeting for 31 March 2026 in Hong Kong.</p>\n<p>The agenda includes:\n1. Reviewing and approving the audited financial results of the Group for the financial year ended 31 December 2025.\n2. Considering a recommendation for a final dividend.\n3. Addressing other routine corporate matters.</p>\n<p>The meeting will be chaired by Dr. Zhang Fabao, who serves as Chairman and Executive Director. The current Board comprises four executive directors (Dr. Zhang Fabao, Dr. Li Xinmei, Mr. Wang Shuai, Mr. Cheng Liang), one non-executive director (Mr. Yan Shengfeng), and three independent non-executive directors (Ms. Liu Tao, Mr. Yu Mingyang, Mr. Lau Yiu Kwan Stanley).</p>\n<p>The company plans to publish the audited annual results following Board approval. Any final dividend recommendation will be announced after the meeting.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02415","symbol_name":"梅斯健康","start_time":0,"source_url":"","article_id":"1106253621","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1106253621","pubTimestamp":1773909867,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"MedSci Healthcare Holdings Limited (Stock Code: 02415) has scheduled a board meeting for 31 March 2026 in Hong Kong. The agenda includes: 1. Reviewing and approving the audited financial results of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02415":"梅斯健康"},"translate_title":"MEDSCI(02415)定于2026年3月31日召开董事会批准2025财年业绩和股息提案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02415":1},"content_text":"MedSci Healthcare Holdings Limited (Stock Code: 02415) has scheduled a board meeting for 31 March 2026 in Hong Kong.\nThe agenda includes:\n1. Reviewing and approving the audited financial results of the Group for the financial year ended 31 December 2025.\n2. Considering a recommendation for a final dividend.\n3. Addressing other routine corporate matters.\nThe meeting will be chaired by Dr. Zhang Fabao, who serves as Chairman and Executive Director. The current Board comprises four executive directors (Dr. Zhang Fabao, Dr. Li Xinmei, Mr. Wang Shuai, Mr. Cheng Liang), one non-executive director (Mr. Yan Shengfeng), and three independent non-executive directors (Ms. Liu Tao, Mr. Yu Mingyang, Mr. Lau Yiu Kwan Stanley).\nThe company plans to publish the audited annual results following Board approval. Any final dividend recommendation will be announced after the meeting.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}